Biotin Supplement Interference With Immunoassays For Parathyroid Hormone And 25-Hydroxyvitamin D In A Patient With Metabolic Bone Disease On Maintenance Hemodialysis

CLINICAL KIDNEY JOURNAL(2020)

引用 3|浏览12
暂无评分
摘要
Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.
更多
查看译文
关键词
biotin, dialysis, end-stage renal disease, parathyroid hormone, 25-hydroxyvitamin D
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要